Objectives: This study aimed at outlining the characteristics of nationwide administrative databases monitoring drug consumption in Europe. Methods: Internet and bibliographic databases (April 2010) were searched and experts in drug utilization (DU) research interviewed to find nationwide administrative medicines consumption databases in Europe, with data for the out- and inpatient healthcare sector. A questionnaire was developed to gather additional information. We collected data providers, websites, accessibility, data sources, healthcare settings, population coverage, medicines-related data, patient and prescriber data, periods covered, and linkage to other databases. Results: Thirty-one administrative nationwide medicine consumption databases in 25 countries were identified. Questionnaires were responded for 20 databases. Eleven provided wholesalers’ sales data, 11 on reimbursed, 5 on prescribed, and 4 on dispensing medicines. Fifteen databases provided inpatient drug consumption data, mainly wholesalers’ sales. Conclusions: Nationwide administrative databases are of value to all stakeholders involved in the conduct and interpretation of post-marketing safety studies, and in the conduct of DU research. The endorsement of the anatomical therapeutic chemical/defined daily dose methodology by these databases contributes to data harmonization. However, there is still a lack of information on inpatient medicines consumption at a patient-level. (PsycINFO Database Record (c) 2016 APA, all rights reserved)
Sources of European drug consumption data at a country level
Ferrer, P., Ballarín, E., Sabaté, M., Laporte, J., Schoonen, M., Rottenkolber, M., Fortuny Moya, J., Hasford, J., & Ibáñez, L. (2014). Sources of European drug consumption data at a country level. International Journal of Public Health, 59(5), 877-87. https://doi.org/10.1007/s00038-014-0564-8
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
COVID-19 diagnosis and SARS-CoV-2 strain identification by a rapid, multiplexed, point-of-care antibody microarray
Use of a web-based portal to return normal individual research results in Early Check